Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
34.1M
-
Shares change
-
+518K
-
Total reported value, excl. options
-
$1.42B
-
Value change
-
+$19.6M
-
Put/Call ratio
-
1.06
-
Number of buys
-
89
-
Number of sells
-
-64
-
Price
-
$41.89
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q2 2016
182 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2016.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.1M shares
of 58.6M outstanding shares and own 58.09% of the company stock.
Largest 10 shareholders include FMR LLC (5.68M shares), WELLINGTON MANAGEMENT GROUP LLP (5.31M shares), BB BIOTECH AG (2.36M shares), VANGUARD GROUP INC (2.11M shares), Capital World Investors (2.08M shares), Flagship Ventures 2007 General Partner LLC (1.93M shares), Capital International Investors (1.5M shares), Clearbridge Investments, LLC (1.46M shares), STATE STREET CORP (899K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (832K shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.